11 Peptides Just Got Greenlit by the FDA (Here's What Changed)

This Is Not Covered — Dr. Ashley Froese — 11 Peptides Just Got Greenlit by the FDA (Here's What Changed)

Channel: This Is Not Covered - Dr. Ashley Froese · Our label: Clinician educator · Source: youtube.com/watch?v=s-Bf12PUgZ4

What this video covers

told us it was happening, and finally on April 15th, 2026, the FDA got the entire peptide community buzzing. And I feel a responsibility to tell you what’s happened here because what people are saying what happened and what actually happened are a little different. Well, the FDA just removed 11 peptides and 12 compounds overall from the category 2 or do not compound list, which since 2023 has been the regulatory equivalent of a ban on compounding these substances in pharmacies. Basically, they said, “Stop making peptides.” And since then, you’ve been…

Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.

Key points, in the speaker’s own framing

• Well, the FDA just removed 11 peptides and 12 compounds overall from the category 2 or do not compound list, which since 2023 has been the regulatory equivalent of a ban on compounding these substances in pharmacies.
• Basically, they said, “Stop making peptides.” And since then, you’ve been able to get Sermorelin PT-141 oxytocin and topical GHK copper from compounding pharmacies, and that might be it.
• So, if you wanted any of the other popular peptides like BPC-157, TB-500, and MOTS-c, well, your doctor and your pharmacy were no longer allowed to get them to you.
• put it, this move, putting so many peptides on the do not compound list, forced peptides into the black market.
• Well, now, and this is important, just because these 12 compounds were moved off of the do not compound list, well, pharmacies legally cannot start compounding these today based on this alone.
• In the regulatory world, if the FDA approves BPC-157 for ulcerative colitis, it becomes legal for a pharmacy to make it.

Read next

• BPC-157 — compound page
• TB-500 — compound page
• MOTS-c — compound page
• Sermorelin — more videos
• PT-141 — more videos
• Oxytocin — more videos
• All videos from this channel

Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.